Kindler HL, Hammel P, Michele Reni, et al. Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. ASCO Annual Meeting 2019, abstract LBA4.
Longkanker vroeg opsporen om de overlevingskans (sterk) te verhogen
dec 2019 | Immuuntherapie, Longoncologie